CS254958B2 - Method of 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(-piperazinyl)-1,8-naphthohydridine-3-carboxyl acid's sesquihydrate preparation - Google Patents
Method of 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(-piperazinyl)-1,8-naphthohydridine-3-carboxyl acid's sesquihydrate preparation Download PDFInfo
- Publication number
- CS254958B2 CS254958B2 CS82998A CS99882A CS254958B2 CS 254958 B2 CS254958 B2 CS 254958B2 CS 82998 A CS82998 A CS 82998A CS 99882 A CS99882 A CS 99882A CS 254958 B2 CS254958 B2 CS 254958B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- sesquihydrate
- trihydrate
- anhydrate
- piperazinyl
- water
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
- C07D213/77—Hydrazine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56020749A JPS57134482A (en) | 1981-02-13 | 1981-02-13 | 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CS99882A2 CS99882A2 (en) | 1987-07-16 |
| CS254958B2 true CS254958B2 (en) | 1988-02-15 |
Family
ID=12035831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS82998A CS254958B2 (en) | 1981-02-13 | 1982-02-12 | Method of 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(-piperazinyl)-1,8-naphthohydridine-3-carboxyl acid's sesquihydrate preparation |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4442101A (de) |
| EP (1) | EP0058614B1 (de) |
| JP (1) | JPS57134482A (de) |
| KR (1) | KR870000322B1 (de) |
| AU (1) | AU547082B2 (de) |
| CA (1) | CA1216292A (de) |
| CS (1) | CS254958B2 (de) |
| DD (1) | DD202573A5 (de) |
| DE (1) | DE3266261D1 (de) |
| DK (1) | DK160046C (de) |
| ES (1) | ES8307793A1 (de) |
| FI (1) | FI71144C (de) |
| HU (1) | HU186473B (de) |
| MX (1) | MX158194A (de) |
| NO (1) | NO156721C (de) |
| PH (1) | PH18177A (de) |
| PL (1) | PL137259B1 (de) |
| YU (1) | YU43785B (de) |
| ZA (1) | ZA82740B (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2758259A (en) * | 1953-06-23 | 1956-08-07 | Mallory & Co Inc P R | Electrolytic capacitor device |
| US2856570A (en) * | 1954-06-02 | 1958-10-14 | Mallory & Co Inc P R | Electrolytic capacitor |
| JPS57134482A (en) * | 1981-02-13 | 1982-08-19 | Dainippon Pharmaceut Co Ltd | 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation |
| DE3308908A1 (de) * | 1983-03-12 | 1984-09-13 | Bayer Ag, 5090 Leverkusen | Bakterizide mittel |
| US4639458A (en) * | 1985-01-22 | 1987-01-27 | Merck & Co., Inc. | Tablet and formulation |
| HUT40429A (en) * | 1985-04-29 | 1986-12-28 | Chinoin Gyogyszer Es Vegyeszet | Process for production of salts of derivatives of kynolin carbonic acid |
| US5466696A (en) * | 1992-09-10 | 1995-11-14 | Warner Lambert Company | Tacrine and cytochrome P450 oxidase inhibitors and methods of use |
| US5422350A (en) * | 1992-09-10 | 1995-06-06 | Warner-Lambert Company | Nitrogen substituted acridine and cytochrome P450 inhibitors and methods of use |
| JP3449658B2 (ja) * | 1994-12-21 | 2003-09-22 | 杏林製薬株式会社 | 安定性に優れた８−アルコキシキノロンカルボン酸水和物並びにその製造方法 |
| GB9820405D0 (en) * | 1998-09-18 | 1998-11-11 | Smithkline Beecham Plc | Process |
| GB9920919D0 (en) | 1999-09-03 | 1999-11-10 | Sb Pharmco Inc | Novel compound |
| GB9920917D0 (en) | 1999-09-03 | 1999-11-10 | Sb Pharmco Inc | Novel process |
| KR100517638B1 (ko) | 2002-04-08 | 2005-09-28 | 주식회사 엘지생명과학 | 게미플록사신 산염의 새로운 제조방법 |
| US7842791B2 (en) * | 2002-12-19 | 2010-11-30 | Nancy Jean Britten | Dispersible pharmaceutical compositions |
| US8629178B2 (en) * | 2009-11-03 | 2014-01-14 | Li Liu | Sodium tanshinone IIA sulfonate hydrate and preparation method and use thereof |
| MX2015011651A (es) * | 2013-03-08 | 2016-08-08 | Melinta Therapeutics Inc | Formas cristalinas de d-glucitol,1-desoxi-1-(metilamino)-,1-(6-ami no-3,5-difluoropiridin-2-il)-8-cloro-6-fluoro-1,4-dihidro-7-(3-hi droxiazetidin-1-il)-4-oxo-3-quinolincarboxilato. |
| KR102214067B1 (ko) | 2014-02-27 | 2021-02-09 | 엘지전자 주식회사 | 산 질화물 형광체, 그 제조 방법 및 이를 이용한 발광 소자 패키지 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3149104A (en) * | 1961-01-03 | 1964-09-15 | Sterling Drug Inc | 4-hydroxy-7-styryl-1, 8-naphthyridine-3-carboxylic acids and esters |
| US3590036A (en) * | 1968-11-18 | 1971-06-29 | George Y Lesher | Naphthyridine-3-carboxylic acids,their derivatives and preparation thereof |
| DE2103805C3 (de) * | 1970-01-28 | 1980-03-20 | Sumitomo Chemical Co., Ltd., Osaka (Japan) | Verfahren zur Herstellung von N-substituierten 6,7-Methylendioxy-4chinolonen |
| US4017622A (en) * | 1972-12-18 | 1977-04-12 | Dainippon Pharmaceutical Co., Ltd. | Piperazine derivatives |
| JPS53141286A (en) * | 1977-05-16 | 1978-12-08 | Kyorin Seiyaku Kk | Novel substituted quinolinecarboxylic acid |
| AR223983A1 (es) * | 1978-08-25 | 1981-10-15 | Dainippon Pharmaceutical Co | Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico |
| JPS5845426B2 (ja) * | 1978-09-29 | 1983-10-08 | 杏林製薬株式会社 | 置換キノリンカルボン酸誘導体 |
| JPS57134482A (en) * | 1981-02-13 | 1982-08-19 | Dainippon Pharmaceut Co Ltd | 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation |
-
1981
- 1981-02-13 JP JP56020749A patent/JPS57134482A/ja active Granted
-
1982
- 1982-02-03 AU AU80173/82A patent/AU547082B2/en not_active Expired
- 1982-02-04 US US06/345,916 patent/US4442101A/en not_active Expired - Lifetime
- 1982-02-05 ZA ZA82740A patent/ZA82740B/xx unknown
- 1982-02-08 YU YU265/82A patent/YU43785B/xx unknown
- 1982-02-11 EP EP82400247A patent/EP0058614B1/de not_active Expired
- 1982-02-11 DE DE8282400247T patent/DE3266261D1/de not_active Expired
- 1982-02-11 DD DD82237353A patent/DD202573A5/de not_active IP Right Cessation
- 1982-02-12 ES ES509538A patent/ES8307793A1/es not_active Expired
- 1982-02-12 MX MX191383A patent/MX158194A/es unknown
- 1982-02-12 PH PH26864A patent/PH18177A/en unknown
- 1982-02-12 DK DK063482A patent/DK160046C/da not_active IP Right Cessation
- 1982-02-12 HU HU82439A patent/HU186473B/hu unknown
- 1982-02-12 NO NO820430A patent/NO156721C/no not_active IP Right Cessation
- 1982-02-12 CA CA000396209A patent/CA1216292A/en not_active Expired
- 1982-02-12 CS CS82998A patent/CS254958B2/cs unknown
- 1982-02-12 PL PL1982235049A patent/PL137259B1/pl unknown
- 1982-02-12 FI FI820466A patent/FI71144C/fi not_active IP Right Cessation
- 1982-02-13 KR KR8200633A patent/KR870000322B1/ko active
Also Published As
| Publication number | Publication date |
|---|---|
| KR870000322B1 (ko) | 1987-02-27 |
| NO820430L (no) | 1982-08-16 |
| FI71144C (fi) | 1986-11-24 |
| YU43785B (en) | 1989-12-31 |
| AU547082B2 (en) | 1985-10-03 |
| EP0058614B1 (de) | 1985-09-18 |
| JPH0243753B2 (de) | 1990-10-01 |
| DK63482A (da) | 1982-08-14 |
| YU26582A (en) | 1986-04-30 |
| MX158194A (es) | 1989-01-16 |
| FI71144B (fi) | 1986-08-14 |
| PH18177A (en) | 1985-04-12 |
| KR830009096A (ko) | 1983-12-17 |
| AU8017382A (en) | 1982-08-19 |
| US4442101A (en) | 1984-04-10 |
| DK160046C (da) | 1991-06-10 |
| DK160046B (da) | 1991-01-21 |
| PL235049A1 (de) | 1982-09-27 |
| JPS57134482A (en) | 1982-08-19 |
| DE3266261D1 (en) | 1985-10-24 |
| CA1216292A (en) | 1987-01-06 |
| ES509538A0 (es) | 1983-08-01 |
| EP0058614A1 (de) | 1982-08-25 |
| CS99882A2 (en) | 1987-07-16 |
| ES8307793A1 (es) | 1983-08-01 |
| DD202573A5 (de) | 1983-09-21 |
| ZA82740B (en) | 1982-12-29 |
| NO156721B (no) | 1987-08-03 |
| PL137259B1 (en) | 1986-05-31 |
| HU186473B (en) | 1985-08-28 |
| FI820466L (fi) | 1982-08-14 |
| NO156721C (no) | 1987-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CS254958B2 (en) | Method of 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(-piperazinyl)-1,8-naphthohydridine-3-carboxyl acid's sesquihydrate preparation | |
| CA2319308C (en) | Pharmaceutical agents | |
| CA2552463C (en) | New compositions containing quinoline compounds | |
| ZA200004178B (en) | Novel Galenic formulations of meloxicam for oral administration. | |
| JPH029040B2 (de) | ||
| KR20030069796A (ko) | 졸피뎀 헤미타르트레이트 | |
| AU2001257213A1 (en) | Zolpidem hemitartrate | |
| JPH0576945B2 (de) | ||
| IL96879A (en) | 4-Tetrahydroimidazo [A] -1,5-pyridinyl benzonitrile hydrochloride, process for its preparation and medicinal preparations containing it | |
| GB2098215A (en) | Thiazolidine derivatives and their preparation and pharmaceutical formulation | |
| CZ299700B6 (cs) | Krystalová modifikace C kyseliny 8-kyano-1-cyklopropyl-7-(1S, 6S-2,8-diazabicyklo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolinkarboxylové, zpusob její výroby a její použití | |
| CZ20013065A3 (cs) | Krystalová modifikace D kyseliny 8-kyano-1-cyklopropyl-7-(1S,6S-2,8-diazabicyklo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolinkarboxylové, způsob její výroby a její pouľití | |
| WO2014026254A1 (en) | Pharmaceutical formulations containing 3-(4-cinnamyl-l-piperazinyl) amino derivatives of 3-formylrifamycin sv and 3-formylrifamycin s and a process of their preparation | |
| US5834492A (en) | Water soluble orally effective iron chelator | |
| JP3281872B2 (ja) | ７−イソインドリン−３−キノリンカルボン酸の塩、その水和物およびそれらを活性成分とする組成物 | |
| MXPA00007921A (en) | Novel galenic formulations of meloxicam for oral administration | |
| EP1541146A1 (de) | Zolpidem hemitartrat solvat | |
| JPS60184084A (ja) | １‐エチル‐３‐カルボキシ‐４‐オキソ‐６，７‐メチレンジオキシ‐１，４‐ジヒドロキノリンの２‐ヒドロキシエチル‐トリメチルアンモニウム塩とその製造方法およびそれからなる薬用組成物 | |
| JPH02221257A (ja) | トリプトファン誘導体の製造方法 | |
| JPH04169585A (ja) | （Ｓ）―１０―（１―アミノシクロプロピル）―９―フルオロ―３―メチル―７―オキソ―２，３―ジヒドロ―７Ｈ―ピリド［１，２，３―ｄｅ］［１，４］ベンゾオキサジン―６―カルボン酸の製剤化方法 | |
| JPS6226273A (ja) | イソキノリン誘導体及びその用途 | |
| NO783005L (no) | Fremgangsmaate for fremstilling av et arylpyridazinylhydrazinsalt |